Frontlight ResearchEarly access
CompletedNo phase
Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension
Key facts
- Who runs it
- Cairo University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 22 Jun 2025
- Ended
- 17 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction
- Record updated
- 18 September 2025
Who can take part
- Age
- 20 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Adult patients with sepsis undergoing source control surgery
Who cannot take part
- Patient with cardiac pathology ( ischemic heart disease or heart failure)
- Patient refusal
- Preoperative hemodynamic instability (defined as MAP < 65 mmHg)
- Rapid sequence induction
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
researchers aim to evaluate the influence of prophylactic noradrenaline infusion on post-induction hypotension
The 2 groups in the trial
- NoradrenalineExisting treatment, for comparison
Noradrenaline will be infused at a fixed rate of 0.2 mic/kg/min at 5 minutes before induction
Treatment: Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction
- ControlNo study treatment, for comparison
Patients will receive normal saline
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Novel Use of Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension in Patients With Surgical Sepsis, a Double Blind Randomized Controlled Trial
- Publications
- Record updated
- 18 September 2025